Form4insider filings, from the source

Insider holders · CIK 0001821586

MoonLake Immunotherapeutics · MLTX

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
da Silva Jorge SantosChief Executive Officer2,774,893—2,774,893Jul 13, 2026 · 4:10 pm EDTForm 4
Kristian ReichChief Scientific Officer35,3892,711,1982,746,587Jul 29, 2026 · 4:10 pm EDTForm 4
Matthias BodenstedtChief Financial Officer1,115,435—1,115,435Jun 23, 2026 · 4:01 pm EDTForm 4
BVF GP HOLDINGS LLCDirector1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4
BVF II GP LLCDirector1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4
BVF I GP LLCDirector1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4
BVF Partners OS Ltd.Director1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4
Biotechnology Value Trading Fund OS LPDirector1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4
Mark N LampertDirector1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4
BIOTECHNOLOGY VALUE FUND II LPDirector1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4
Inc/il BvfDirector1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4
BVF PARTNERS L P/ILDirector1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4
BIOTECHNOLOGY VALUE FUND L PDirector1,039,238—1,039,238Jun 22, 2026 · 4:50 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.